- Home
- VSTM vs WALD Comparison
VSTM vs WALD Comparison
Compare VSTM & WALD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSTM
- WALD
- Stock Information
- Founded
- VSTM 2010
- WALD 1988
- Country
- VSTM United States
- WALD United States
- Employees
- VSTM N/A
- WALD N/A
- Industry
- VSTM Biotechnology: Pharmaceutical Preparations
- WALD Package Goods/Cosmetics
- Sector
- VSTM Health Care
- WALD Consumer Discretionary
- Exchange
- VSTM Nasdaq
- WALD Nasdaq
- Market Cap
- VSTM 345.6M
- WALD 306.3M
- IPO Year
- VSTM 2012
- WALD 2021
- Fundamental
- Price
- VSTM $8.23
- WALD $1.73
- Analyst Decision
- VSTM Strong Buy
- WALD Strong Buy
- Analyst Count
- VSTM 9
- WALD 5
- Target Price
- VSTM $12.75
- WALD $5.16
- AVG Volume (30 Days)
- VSTM 3.1M
- WALD 142.8K
- Earning Date
- VSTM 08-07-2025
- WALD 08-18-2025
- Dividend Yield
- VSTM N/A
- WALD N/A
- EPS Growth
- VSTM N/A
- WALD N/A
- EPS
- VSTM N/A
- WALD N/A
- Revenue
- VSTM $2,137,000.00
- WALD $273,868,000.00
- Revenue This Year
- VSTM $55.63
- WALD $14.78
- Revenue Next Year
- VSTM $453.72
- WALD $15.84
- P/E Ratio
- VSTM N/A
- WALD N/A
- Revenue Growth
- VSTM N/A
- WALD 25.55
- 52 Week Low
- VSTM $2.24
- WALD $1.60
- 52 Week High
- VSTM $9.10
- WALD $4.74
- Technical
- Relative Strength Index (RSI)
- VSTM 73.06
- WALD 37.82
- Support Level
- VSTM $7.44
- WALD $1.61
- Resistance Level
- VSTM $8.76
- WALD $2.10
- Average True Range (ATR)
- VSTM 0.64
- WALD 0.16
- MACD
- VSTM 0.23
- WALD 0.01
- Stochastic Oscillator
- VSTM 84.05
- WALD 23.64
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
About WALD Waldencast plc
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.